SecBot SecBot
8-K ·Filed Apr 21, 2026

PAXH

PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.
BEARISH
Impact 8/10
Horizonweeks Processed6mo ago SEC0001079973-26-000518
8-K Item 4.02: Non-reliance on financial statements (restatement)
Actionable Insight ▼ Bearish

Traders should expect downward pressure on PAXH shares due to the restatement and ongoing material weakness in controls. Monitor the amended 10-Q filing for the extent of the financial corrections and potential legal or regulatory fallout.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
PAXH ▲ 0.00% at T+60d
SHORT call ✗ call lost 0.00% · α vs SPY +4.78% · entry $0.2200 → $0.2200
Entry = T+0 close
Apr 21, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.39%
$0.2200
settled 6mo ago
T+5d
0.00%
call 0.00% · α +0.05%
$0.2200
settled 6mo ago
T+20d
0.00%
call 0.00% · α +3.17%
$0.2200
settled 5mo ago
T+60d
0.00%
call 0.00% · α +4.78%
$0.2200
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

PreAxia Health Care Payment Systems Inc. announced it can no longer rely on its previously issued financial statements for the three months ended August 31, 2025, due to material errors in stock award valuation, timing, and lack of option disclosures. The company plans to restate the financials and continues to report a material weakness in internal controls.

Key Facts

  • The company is restating financial statements for the three months ended August 31, 2025.
  • Errors relate to stock award valuation, timing, and lack of option disclosures.
  • Management concluded the errors are material and the financials should no longer be relied upon.
  • The company continues to report a material weakness in internal control over financial reporting.
  • M&K CPAs will oversee the review of the amended 10-Q.

Financial Impact

Material impact expected to the financial statements for the three months ended August 31, 2025, though specific dollar amounts are not disclosed.

revenuenet incomeequitydisclosures

Risk Factors

  • Shareholder litigation risk is high due to the restatement and disclosure failures.
  • Regulatory scrutiny from the SEC is likely given the material weaknesses in internal controls.
  • Further negative disclosures or delays in the restatement process could exacerbate investor distrust.

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001079973-26-000518
Document: 0001079973-26-000518-index-headers.html0001079973-26-000518
Document: 0001079973-26-000518-index.html0001079973-26-000518
Document: 0001079973-26-000518.txt0001079973-26-000518
4 reports for PAXH
Performance horizon
0% Hit rate @ T+20 0 of 3 directional calls Went positive at some point 0 of 3 best @ T+1· 0.00%Feb 25, 2026
Filters
Rows
Reports for PAXH — sortable, filterable
TypeNow
Sep 11, 2026
6w ago
10-Q/A
BEARISH ★ 6/10
$0.2200 $0.2200· 0.00%▲ +2.12%$0.2200 (+0.00%)
Apr 21, 2026
27w ago
8-K
BEARISH ★ 8/10
$0.2200 $0.2200· 0.00%▲ +3.17%$0.2200 (+0.00%)
Mar 5, 2026
33w ago
8-K/A
BEARISH ★ 8/10
$0.2200 $0.2200· 0.00%▼ −2.04%$0.2200 (+0.00%)
Feb 25, 2026
34w ago
8-K
BEARISH ★ 8/10
$0.2200 $0.2200· 0.00%▼ −6.40%$0.2200 (+0.00%)
Showing 4 of 4

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 21, 2026